This page contains a Flash digital edition of a book.
| AESTHETIC SOLUTIONS | ARTICLE


Figure 1 Intradermal injections of cross-linked hyaluronic acid


Figures 2 and 3 (below)


Intralesional injections of hyaluronidase


allergic reaction. Performing this test is quite simple: 1500 IU of hyaluronidase are diluted in 8–10 ml saline solution, with each ml containing up to 150 IU. Then, 0.1 ml of this dilution is injected subcutaneously to the forearm. The patient is kept in the clinic for an average of 60 minutes. Any reaction (e.g. itching, swelling, redness) at the injection point signifies that the patient should not receive treatment. A subcutaneous test is recommended for all patients prior to the injection of hyaluronidase.


Hyaluronidase for reducing the risk of necrosis after an excess of hyaluronic acid Hyaluronidase, by quickly breaking down the hyaluronic acid polymer, is able to reduce the risk of skin necrosis secondary to vascular compression if injected early, according to the medical literature2–4


. Unfortunately,


injection after 24 hours has been shown to be rather inefficient. Kim et al2


experimented using intra-arterial


injection of hyaluronic acid in a rabbit ear, followed by an injection of hyaluronidase both 4 and 24 hours later. A late injection did not reduce the size of necrosis, while an earlier injection significantly reduced the size of skin necrosis. Hyaluronidase should therefore be immediately injected in cases of symptoms suggesting vascular compression .


Hyaluronidase in cellulite treatment or post-lipoplasty fibrotic reaction Hyaluronidase has been widely used in the past to treat fibrotic cellulite: 1500 IU are diluted in 8–10 ml of saline solution and deeply injected (more than 1 cm deep) in fibrotic areas. A maximum of 3000 UI are used per session for a maximum of two sessions (one per week) in order to limit the risk of allergic reactions. Allergy tests should be performed before every injection. The authorsÕ experience has found that the early injection of hyaluronidase has been able to reduce fibrosis and remaining oedema following breast lipoplasty or double chin lipoplasty in male


patients. Breast and chin lipoplasties often induce a strong fibrotic reaction that disappears slowly, sometimes over a number of months. The injection of hyaluronidase also allows for a dramatic reduction or disappearance of postoperative fibrosis in a matter of days. One injection of 500 UI hyaluronidase (1500 UI diluted in 9 ml saline solution; inject 3 ml in a fan pattern) will be sufficient for post-lipoplasty double chin fibrosis reduction. Massage is carried out immediately after injection in


order to allow a better diffusion of the product. During the massage, the doctor can feel that the fibrosis is immediately decreased. Intradermal tests should be carried out before every injection session to verify the absence of a type I allergy to hyaluronidase.


Hyaluronidase, by quickly


breaking down the hyaluronic acid polymer, is able to reduce the risk of skin necrosis secondary to vascular compression if injected early, according to the medical literature.


Hyaluronic acid filler excesses The injection of hyaluronidase fortunately erases any cross-linked hyaluronic acid very quickly, but the speed will generally depend on the strength of the cross-linking. In these cases, the delay between the injection of hyaluronic acid and hyaluronidase is not relevant ® even when injected years later, hyaluronidase is able to cut the polymer. Reports show that hyaluronidase is able to dissolve hyaluronic acid injections in the periorbital area, even 5 years after the original injection. Again, intradermal testing should be carried out prior to injection. The task is to evaluate the volume and concentration of hyaluronidase to be injected in order


prime-journal.com | April/May 2012 ❚ 35


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84